Gemphire to Present at the Oppenheimer Annual Healthcare Conference and the H.C. Wainwright NASH Investor Event

LIVONIA, Mich., March 16, 2017 (GLOBE NEWSWIRE) — Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and NASH, today announced that management will provide a corporate update at the Oppenheimer 27th Annual Healthcare Conference, taking place March 21-22 at the Westin New York Grand Central Hotel, and will also present at the 1st Annual H.C. Wainwright NASH Investor Event, taking place April 3, 2017, at the St. Regis Hotel in New York City.

Copyright © 2015 All Latest News.

To Top